[1]
M. Sales, M. E. P. de Freitas, L. F. de Oliveira, M. E. L. Barbosa, Ê. N. de Oliveira, and A. L. dos Santos, “CARDIOVASCULAR SAFETY OF MENOPAUSAL HORMONE THERAPY: INFLUENCE OF ADMINISTRATION ROUTE, FORMULATION AND WINDOW OF OPPORTUNITY”, REASE, vol. 12, no. 10, pp. 1–15, Oct. 2026, doi: 10.51891/rease.v12i10.30830.